Regional distribution of epidermal growth factor, testosterone and dihydrotestosterone in benign prostatic hyperplasia tissue.
In benign prostatic hyperplasia (BPH), basic fibroblast growth factor (bFGF) is found to have a regional distribution, with concentrations in the periurethral zone (where the primitive fibrostromal nodule originates) higher than those of the peripheral subcapsular zone. The aim of the present investigation was to verify whether androgens and epidermal growth factor (EGF) are uniformly distributed from the periurethral to the peripheral zone or whether they show regional differences. Tissue samples, removed by transvesical resection from nine untreated BPH patients, sectioned in periurethral, subcapsular, and intermediate zones, were examined. In the periurethral zone, dihydrotestosterone (DHT), testosterone, and EGF, determined by radioimmunoassay (RIA) techniques after purification on Celite microcolumns and Sep-pak C18 cartridge, showed values significantly higher (mean +/- SD: 1121 +/- 482 pg, 250 +/- 129 pg, and 6.89 +/- 3.28 ng/mg DNA, respectively; P < 0.01) than those of the subcapsular zone (489 +/- 190 pg, 114 +/- 70 pg, and 3.40 +/- 1.90 ng/mg DNA, respectively). A positive linear correlation between EGF, testosterone, and DHT was also observed. The regional distribution of EGF, testosterone, and DHT was similar to that found for bFGF: the highest levels of these factors in the periurethral region allow us to hypothesize on their possible involvement in the rewakening of mesenchymal tissue, leading to the formation of the primitive fibrostromal nodule and then to BPH development.
Sciarra
F
F
Istituto di Clinica Medica Generale V, Università degli Studi di Roma La Sapienza, Italy.
Monti
S
S
Adamo
M V
MV
Palma
E
E
Toscano
V
V
d'Eramo
G
G
di Silverio
F
F
D003627:Data Interpretation, Statistical; D013196:Dihydrotestosterone / Q000032:analysis*; D004815:Epidermal Growth Factor / Q000032:analysis*; D016222:Fibroblast Growth Factor 2 / Q000032:analysis; D006801:Humans; D008297:Male; D011467:Prostate / Q000737:chemistry* / Q000166:cytology; D011470:Prostatic Hyperplasia / Q000473:pathology*; D011863:Radioimmunoassay; D013739:Testosterone / Q000032:analysis*
D013196:Dihydrotestosterone; D016222:Fibroblast Growth Factor 2; D013739:Testosterone; D004815:Epidermal Growth Factor